FP2030 and the CTI Exchange, in partnership with Population Council, PSI, RHSC, and FHI 360, will host an exploration of innovative contraceptive technology, including the Nestorone®/Testosterone transdermal gel, biodegradable implants, and multipurpose prevention technologies. This webinar will share a vision for what a user-led, context-appropriate, and gender inclusive contraceptive method mix could look like for the next generation of potential contraceptive users.
- Kirsten Vogelsong, Bill and Melinda Gates Foundation
- Regine Sitruk-Ware, Population Council
- Kavita Nanda, FHI 360
- Bethany Young-Holt, CAMI Health + IMPT
This event is the first of several events exploring innovation in new contraceptive method introduction. The next webinar in this series, “The Future of the Modern Contraceptive Method Mix: From Ideas to Reality,” will discuss how global funders of contraceptive R&D can support new ideas and how implementers can ensure equitable, sustainable access.
Additional details to come.
*Simultaneous translation available in both French and Spanish